Study Stopped
difficulties encountered in recruiting and stop of funding
Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group
Bipolife
2 other identifiers
interventional
42
1 country
1
Brief Summary
Bipolar disorder is a condition characterized by succession of episodes- manic, hypomanic, and depressive episodes. Major risks factors of relapses are poor compliance, sleep disorder, and toxics consumption. The aims of psychoeducation programs are to increase compliance and knowledge about bipolar disorder. Serious game are supposed, in bipolar disorder, to strengthen the efficacy of psychoeducation programs. Bipolife® is a serious game which purpose is to help bipolar patients to deal with their conditions, through 3 mains messages : to pursue the treatment, to have daily routine and to request the psychiatrist in case of relapse. This is a multicentric randomized controlled study with two harms parallels. After a classic psychoeducation group program, patients are randomized in two groups : interventional group and control group with treatment as usual. The main objective is to evaluate the observance in the two groups. The other objectives are to evaluate daily routine, global functioning, and access to health care. Evaluations are realized at one and four months after inclusion visit. Acceptability and satisfaction about the serious game Bipolife® will be assessed in the interventional group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2014
CompletedFirst Submitted
Initial submission to the registry
July 15, 2016
CompletedFirst Posted
Study publicly available on registry
October 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2017
CompletedAugust 26, 2022
August 1, 2022
2.4 years
July 15, 2016
August 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compliance rate
Evaluation of patient compliance by Medication Adherence Rating Scale (MARS) score.
At 4 months after the inclusion
Secondary Outcomes (6)
Evolution of toxic consumption
Between 1 and 4 months after the inclusion
Evolution of sleep disturbance
Between 1 and 4 months after the inclusion
Evolution of the alimentation
Between 1 and 4 months after the inclusion
Global functioning
At 1 and 4 months after the inclusion
Ability to access health care in emergency description : number of emergency consultation for psychiatric reason
At 1 and 4 months after the inclusion
- +1 more secondary outcomes
Study Arms (2)
Interventional group
EXPERIMENTALBipolife group
Control group
NO INTERVENTIONNo specific intervention, treatment as usual
Interventions
The participant is proposed to play to the serious game Bipolife® with following instructions : * At least one connection per week during 4 weeks * Connection time is free On add on of usual treatment After the 4 weeks and the first visit (V1), the participant can continue to participate to the serious game as much as he wishes, without any specific instructions. After connecting to the site www.bipolar.ubi.com, the participant is proposed to create his avatar and conduct him on his house. He realizes different kind of daily actions (like sleeping, sport activity, cooking) ; every action lead to win or to loose "energy" and "mood" points. The final aim is to stabilize the avatar's mood. Thanks to this experience, the participant can learn to distinguish positive and negative actions impacting on his condition.
Eligibility Criteria
You may qualify if:
- diagnosis of bipolar disorder according to the Diagnostic and Statistical Manual (DSM) IV
- euthymic status at least since 3 months
- participation to a psychoeducation group ending on the 15 last days
- realized at less 50% of the sessions of psychoeducation group
- free access to a computer with internet connection
- signed informed consent
You may not qualify if:
- decline of participation
- patient on protective measures (guardianship or trusteeship)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Montpellier Hospital
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2016
First Posted
October 18, 2016
Study Start
December 9, 2014
Primary Completion
May 12, 2017
Study Completion
May 12, 2017
Last Updated
August 26, 2022
Record last verified: 2022-08